7N7G image
Deposition Date 2021-06-10
Release Date 2022-07-27
Last Version Date 2023-10-18
Entry Detail
PDB ID:
7N7G
Title:
Crystal Structure of FosB from Enterococcus faecium with Fosfomycin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 41 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Metallothiol transferase FosB
Gene (Uniprot):fosB
Chain IDs:A, B
Chain Length:139
Number of Molecules:2
Biological Source:Enterococcus faecium
Primary Citation
Structural and functional characterization of fosfomycin resistance conferred by FosB from Enterococcus faecium.
Protein Sci. 31 580 590 (2022)
PMID: 34882867 DOI: 10.1002/pro.4253

Abstact

The Gram-positive pathogen Enterococcus faecium is one of the leading causes of hospital-acquired vancomycin resistant enterococci (VRE) infections. E. faecium has extensive multidrug resistance and accounts for more than two million infections in the United States each year. FosB is a fosfomycin resistance enzyme found in Gram-positive pathogens like E. faecium. Typically, the FosB enzymes are Mn2+ -dependent bacillithiol (BSH) transferases that inactivate fosfomycin through nucleophilic addition of the thiol to the antibiotic. However, our kinetic analysis of FosBEf shows that the enzyme does not utilize BSH as a thiol substrate, unlike the other well characterized FosB enzymes. Here we report that FosBEf is a Mn2+ -dependent L-cys transferase. In addition, we have determined the three-dimensional X-ray crystal structure of FosBEf in complex with fosfomycin at a resolution of 2.0 Å. A sequence similarity network (SSN) was generated for the FosB family to investigate the unexpected substrate selectivity. Three non-conserved residues were identified in the SSN that may contribute to the substrate selectivity differences in the family of enzymes. Our structural and functional characterization of FosBEf establishes the enzyme as a potential target and may prove useful for future structure-based development of FosB inhibitors to increase the efficacy of fosfomycin.

Legend

Protein

Chemical

Disease

Primary Citation of related structures